Advanced Medical Solutions
Advanced Medical Solutions, often referred to as AMS, is a leading provider of innovative wound care and surgical solutions, headquartered in the United Kingdom. Established in 1993, the company has made significant strides in the medical industry, particularly in the development of advanced wound management products and surgical adhesives. With a strong presence in Europe, North America, and Asia, AMS is renowned for its unique offerings, including hydrocolloid dressings and advanced tissue adhesives that enhance patient outcomes. The company has achieved notable milestones, such as receiving multiple regulatory approvals and expanding its product range to meet diverse clinical needs. Recognised for its commitment to quality and innovation, Advanced Medical Solutions continues to solidify its market position as a trusted partner in healthcare, dedicated to improving the lives of patients worldwide.
DitchCarbon Score
How does Advanced Medical Solutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Advanced Medical Solutions's score of 28 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Advanced Medical Solutions's reported carbon emissions
In 2023, Advanced Medical Solutions reported total carbon emissions of approximately 50.5 million tonnes CO2e. This figure includes 1.34 million tonnes from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 1.34 million tonnes from Scope 2 emissions, related to the generation of purchased electricity. The majority of their emissions, about 48.8 million tonnes, fall under Scope 3, which encompasses indirect emissions from the value chain. Comparing the data from previous years, emissions decreased from approximately 51 million tonnes in 2021 to about 50.5 million tonnes in 2023. Notably, Scope 1 emissions have also seen a reduction from 1.72 million tonnes in 2021 to 1.34 million tonnes in 2023, indicating a positive trend in managing direct emissions. Despite these reductions, Advanced Medical Solutions has not set specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further strategic planning in their sustainability efforts. Overall, while the company has made strides in reducing emissions, a more structured approach to climate commitments could enhance their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 1,716,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,352,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 46,649,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Advanced Medical Solutions is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
